/Investor DB

Hankey Capital

Late Stage

Find your way into Hankey Capital

Sign up to see every warm intro you have to Hankey Capital

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Hankey Capital team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit
Stage
Late Stage
Tracked investments
1
IPOs
1

What they invest in

from 1 of 1 portfolio companies

Biotech ×1

HQs:United States×1

Investments · 1 tracked

founders shown can be your intro path
Bone BiologicsinNASDAQ: BBLG

Bone Biologics develops a medical device combining a recombinant human protein called NELL-1 with demineralized bone matrix for use in spinal fusion and other orthopedic procedures to promote controlled bone regeneration.

BiotechBoston, US

Steve La Neve(Executive Officer)Jeffrey Frelick(Chief Executive Officer and President)Deina H. Walsh(Chief Financial Officer)inChia Soo(Director)Benjamin Wu(Director)

BoardBruce Stroever(Director)

Exits · 1

1 IPOs

Bone BiologicsNASDAQ: BBLG

IPO stake values · per SEC filings

Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.

CompanyOwnedIPO priceAt IPOStake value
Bone Biologics51.5%$1.35Oct 2022$10.2M

Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).

Frequently asked questions

What stage does Hankey Capital invest at?
Hankey Capital invests at the Late Stage stage.

Similar investors

Featured in lists